A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer

Seminars in Radiation Oncology

Volumn 14, Issue 4, 2004, Pages 298-307

  Miller, Keith L ^a   Shafman, Timothy D ^a   Marks, Lawrence B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; PROTEIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

CANCER CHEMOTHERAPY; CANCER RISK; CELL PROTECTION; CLINICAL PRACTICE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; LUNG INJURY; LUNG TOXICITY; MEDICAL ASSESSMENT; MORTALITY; PREDICTION; PREMEDICATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TECHNIQUE; TOBACCO; TREATMENT OUTCOME;

EID: 8844225708     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2004.06.004     Document Type: Article

References (73)

1. Y. Segawa, N. Takigawa, M. Kataoka Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer Int J Radiat Oncol Biol Phys 39 1997 91 98
2. X.L. Fu, G.L. Jiang, L.J. Wand Hyperfractionated accelerated radiation therapy for non-small cell lung cancer Clinical phase I/II trial Int J Radiat Oncol Biol Phys 39 1997 545 552
3. J. Monson, P. Stark, J. Reilly Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma Cancer 82 1998 842 850
4. J. Nyman, B. Bergman, C. Mercke Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer Acta Oncol 37 1998 539 545
5. M. Hernando, L. Marks, G. Bentel Radiation-induced pulmonary toxicity a dose-volume histogram analysis in 201 patients with lung cancer Int J Radiat Oncol Biol Phys 51 2001 650 659
6. M. Perry, W.L. Eaton, K.J. Propert Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung N Engl J Med 316 1987 912 918
7. C.A. Perez, K. Stanley, P. Rubin A prospective randomized study of various radiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung Cancer 45 1980 2744 2753
8. J.R. Simpson, M.E. Francis, R. Perez-Tamayo Palliative radiotherapy for inoperable carcinoma of the lung Final report of a RTOG multi-institutional trial Int J Radiat Oncol Biol Phys 11 1985 751 758
9. R.O. Dillman, S.L. Seagren, K.J. Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
10. C. Schaake-Koning, W. van den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530
11. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and Cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
12. W.T. Sause, C. Scott, S. Taylor Radiation Therapy Oncology Group (RTOG) 88-08 Eastern Cooperative Oncology Group (ECOG) 4588 Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 1995 198 205
13. R.I. Rothwell, S.A. Kelley, C.A.F. Joslin Radiation pneumonitis in patients treated for breast cancer Radiother Oncol 4 1985 9 14
14. R.T. Woel, M.T. Munley, D. Hollis The time course of radiation therapy-induced reductions in regional perfusion a prospective study with >5 years of follow-up Int J Radiat Oncol Biol Phys 52 2002 58 67
15. Y. Seppenwoolde, S.H. Muller, J. Theuws Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer Int J Radiat Oncol Biol Phys 47 2000 681 691
16. Z. Vujaskovic, M.S. Anscher, Q.F. Feng Radiation-induced hypoxia may perpetuate late normal tissue injury Int J Radiat Oncol Biol Phys 50 2001 851 855
17. Common terminology criteria for adverse events v 3.0 (CTCEA). Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed June 28, 2004
18. L.B. Marks, X. Yu, Z. Vujaskovic Radiation-induced lung injury Semin Radiat Oncol 13 2003 333 345
19. L. Cocchiarella, G.B.J. Andersson Guides to the Evaluation of Permanent Impairment 5th ed. 2001 AMA Press Chicago, IL3
20. P. Armstrong, J. Congleton, Fountain Guidelines on the selection of patients with lung cancer for surgery Thorax 56 2001 89 108
21. C. Wyser, P. Stulz, M. Soler Prospective evaluation of an algorithm for the functional assessment of lung resection candidates Am J Resp Crit Care Med 159 1999 1450 1456
22. D. Datta, B. Lahiri Preoperative evaluation of patients undergoing lung resection surgery Chest 123 2003 2096 2103
23. G.N. Olsen, A.J. Block, J.A. Tobias Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning Chest 66 1974 13 16
24. M. Fan, L.B. Marks, D. Hollis Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?. J Clin Oncol 19 2001 543 550
25. D. Van Nostrand, M.O. Kjelsberg, E.W. Humphrey Preresection evaluation of risk from pneumonectomy Surg Gynecol Obstet 127 1968 306 312
26. D.A. Holden, T.W. Rice, K. Stelmach Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection Chest 102 1992 1774 1779
27. M.A. Beckles, S.G. Spiro, G.L. Colice The physiologic evaluation of patients with lung cancer being considered for resectional surgery Chest 123 2003 105S 114S
28. M. Beccarria, A. Corsico, P. Fulgoni Lung cancer resection the prediction of postsurgical outcomes should include long-term functional results Chest 120 2001 37 42
29. D.J. Kearney, T.H. Lee, J.J. Reilly Assessment of operative risk in patients undergoing lung resection Importance of predicted pulmonary function Chest 105 1994 753 759
30. K. Mah, T.J. Keane, J. Van Day Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage A prospective clinical study Int J Radiat Oncol Biol Phys 28 1994 563 574
31. K.R. Arbetter, U.B.S. Prakash, H. Tazelaar Radiation-induced pneumonitis in the "nonirradiated" lung Mayo Clin Proc 74 1999 27 36
32. G.W. Morgan, S.N. Breit Radiation and the lung a reevaluation of the mechanisms mediating pulmonary injury Int J Radiat Oncol Biol Phys 31 1995 361 369
33. K.L. Miller, S.M. Zhou, R.C. Barrier Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer Int J Radiat Oncol Biol Phys 56 2003 611 615
34. J.H. Rubenstein, M.P. Richter, P.J. Moldofsky Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing Int J Radiat Oncol Biol Phys 15 1988 83 87
35. N. Choi, D.J. Kanarek, H. Kazemi Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary function studies in predicting post-radiotherapy pulmonary function before radiotherapy Cancer Treat Sym 2 1985 119 130
36. R.P. Abratt, P.A. Willcox, J.A. Smith Lung cancer in patients with borderline lung functions--zonal lung perfusion scans at presentation and lung function after high dose irradiation Radiother Oncol 19 1990 317 322
37. W.J. Curran, P.J. Moldofsky, L.J. Solin Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma Int J Radiat Oncol Biol Phys 24 1992 31 36
38. J.C.M. Theuws, S.L.S. Kwa, A.C. Wagenaar Prediction of overall pulmonary function loss in relation to the 3-D dose distribution, for patients with breast cancer and malignant lymphoma Radiother Oncol 49 1999 233 243
39. M. Roach, D.R. Gandara, H.S. Yuo Radiation pneumonitis following combined modality therapy for lung cancer analysis of prognostic factors J Clin Oncol 13 1995 2606 2612
40. T.J. Robnett, M. Machtay, E.F. Vines Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 48 2000 89 94
41. R.W. Byhardt, L. Martin, T.F. Pajak The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol Int J Radiat Oncol Biol Phys 27 1993 537 544
42. L.B. Marks Dosimetric predictors of radiation-induced lung injury Int J Radiat Oncol Biol Phys 54 2002 313 316
43. J.G. Armstrong, M.F. Zelefsky, S.A. Leibel Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer Ann Oncol 6 1995 693 697
44. D. Oetzel, P. Schraube, F. Hensely Estimations of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis Int J Radiat Oncol Biol Phys 33 1995 455 460
45. M. Graham, J. Purdy, B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329
46. S.L.S. Kwa, J.C.M. Theuws, A. Wagenaar Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis Radiother Oncol 48 1998 61 69
47. E.D. Yorke, A. Jackson, K.E. Rosenzweig Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 54 2002 329 339
48. K. Tsujino, S. Hirota, M. Endo Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 55 2003 110 115
49. X. Yu, S. Zhou, D. Kahn Predicting RT-induced pulmonary symptoms based on the dose to the superior vs inferior lung in patients irradiated for lung cancer. Int J Radiat Oncol Biol Phys 57 2003 415S
50. B. Dautzenburg, R. Arriagada, A.G. Chammard A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma Cancer 86 1999 265 273
51. P. Lind, L.B. Marks, D. Hollis Receiver operator curves (ROC) analysis of predictors for radiation-induced symptomatic lung injury Int J Radiat Oncol Biol Phys 54 2002 340 347
52. M.S. Anscher, L.B. Marks, G. Sherouse Changes in plasma transforming growth factor-beta levels during pulmonary irradiation Int J Radiat Oncol Biol Phys. 30 1994 671 676
53. X.L. Fu, H. Huang, G. Bentel Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor B Int J Radiat Oncol Biol Phys 50 2001 899 908
54. Y. Chen, J. Williams, E. Hernady Radiation pneumonitis and early circulatory cytokine markers Semin Radiat Oncol 12 suppl 1 2002 26 33
55. G.S. Sibley Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma smaller volumes and higher doses--A review Cancer 82 1998 433 438
56. S.H. Abid, V. Malhotra, M.C. Perry Radiation-induced and chemotherapy-induced pulmonary injury Curr Opin Oncol 13 2001 242 248
57. S. McDonald, P. Rubin, Phillips Injury to the lung from cancer therapy clinical syndromes, measurable endpoints, and potential scoring systems Int J Radiat Oncol Biol Phys 31 1995 1187 1203
58. S. Johansson, L. Bjermer, L. Franzen Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients Radiother Oncol 49 1998 41 47
59. J.C.M. Theuws, S.L.S. Kwa, A.C. Wagenaar Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer Radiother Oncol 48 1998 33 43
60. M. Garipagaoglu, M.T. Munley, D. Hollis The effect of patient-specific factors on radiation-induced regional lung injury Int J Radiat Oncol 45 1999 331 338
61. N.C. Choi, D.J. Kanarek Toxicity of thoracic radiotherapy on pulmonary function in lung cancer Lung Cancer 10 suppl 1 1994 S219 S230
62. L.B. Marks, D. Hollis, M. Munley The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests Cancer 88 2000 2135 2141
63. D. Antonadou, N. Coliarkis, M. Synodinou A randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer Int J Radiat Oncol Biol Phys 51 2002 915 922
64. R. Komaki, J.S. Lee, B. Kaplan Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer Preliminary results Semin Radiat Oncol 12 suppl 1 2002 46 49
65. M. Werner-Wasik, C. Scott, B. Movsas Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT) Results of the Radiation Therapy Oncology Group (RTOG) 98-01 study Int J Radiat Oncol Biol Phys 57 2003 S216
66. M.S. Anscher, L.B. Marks, T.D. Shafman Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation J Clin Oncol 19 2001 3758 3765
67. J.S.A. Belberdos, K. De Jagier, W.D. Heemsbergen First results of a phase I/II dose escalation trial in non-small cell lung cancer using three dimensional conformal radiotherapy Radiother Oncol 66 2003 119 126
68. E.C. Ford, G.S. Mageras, E. Yorke Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging Int J Radiat Oncol Biol Phys 52 2002 522 531
69. N.J. Gross, K.R. Narine, R. Wade Protective effect of corticosteroids on radiation pneumonitis in mice Radiat Res 113 1988 112 119
70. S.W. Cosgriff, M.M. Kligerman Use of ACTH and cortisone in the treatment of post-radiation pulmonary reactions Radiology 57 1951 536 540
71. S. Delanian, R. Porcher, S. Balla-Mekias Randomized placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis J Clin Oncol 21 2003 2545 2550
72. W.F. Ward, P.P. Lin, P.S. Wong Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor Captopril evaluated by high-resolution computed tomography Radiation Res 135 1993 81 87
73. P.M. Resnikoff, A.L. Ries Maximizing functional capacity. Pulmonary rehabilitation and adjunctive measures Respir Care Clin N Am 4 1998 475 492